The Current Ratio as of December 2025 (TTM) for Neurotech International Limited (NTI.AX) is 11.34

According to Neurotech International Limited’s latest financial reports and current stock price. The company's current Current Ratio is 11.34. This represents a change of -41.68% compared to the average of 19.45 of the last 4 quarters.

Neurotech International Limited (NTI.AX) Historical Current Ratio (quarterly & annually)

How has NTI.AX Current Ratio performed in the past?

The mean historical Current Ratio of Neurotech International Limited over the last ten years is 11.25. The current 11.34 Current Ratio has changed 9.98% with respect to the historical average. Over the past ten years (40 quarters), NTI.AX's Current Ratio was at its highest in in the June 2024 quarter at 38.81. The Current Ratio was at its lowest in in the December 2015 quarter at 0.

Neurotech International Limited (NTI.AX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Neurotech International Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Neurotech International Limited (NTI.AX) Average Current Ratio

How has NTI.AX Current Ratio performed in the past?

The current Current Ratio of Neurotech International Limited (NTI.AX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Neurotech International Limited (NTI.AX) Current Ratio vs. Peers

How is NTI.AX’s Current Ratio compared to its peers?

Neurotech International Limited’s Current Ratio is greater than Atomo Diagnostics Limited (3.03), greater than Althea Group Holdings Limited (0.69), greater than TruScreen Group Limited (2.47), greater than Control Bionics Limited (1.24), greater than OncoSil Medical Limited (1.67), less than Enlitic, Inc. (0), greater than BTC Health Limited (3.16), greater than Patrys Limited (1.73), greater than MedAdvisor Limited (1.73), less than Tissue Repair Ltd (22.40),

Build a custom stock screener for Neurotech International Limited (NTI.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neurotech International Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Neurotech International Limited (NTI.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Neurotech International Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.